NXTC
NextCure, Inc.NASDAQHealthcare$10.72+2.89%ClosedMarket Cap: $28.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.11
P/S
0.00
EV/EBITDA
-0.16
DCF Value
$7.07
FCF Yield
-167.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-152.9%
ROA
-111.3%
ROIC
-141.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-9.8M | $-9.4M | $-2.69 | — |
| FY 2025 | $0.00 | -Infinity% | $-57.6M | $-55.8M | $-19.65 | — |
| Q3 2025 | $0.00 | NaN% | $-8.9M | $-8.6M | $-3.22 | — |
| Q2 2025 | $0.00 | NaN% | $-27.3M | $-26.8M | $-11.29 | — |
| Q1 2025 | $0.00 | NaN% | $-11.6M | $-11.0M | $-4.70 | — |
| Q4 2024 | $0.00 | NaN% | $-12.5M | $-11.6M | $-4.97 | — |
| FY 2024 | $0.00 | NaN% | $-59.7M | $-55.7M | $-23.88 | — |
| Q3 2024 | $0.00 | NaN% | $-12.5M | $-11.5M | $-4.95 | — |
| Q2 2024 | $0.00 | -Infinity% | $-16.5M | $-15.4M | $-6.61 | — |
| Q1 2024 | $0.00 | NaN% | $-18.3M | $-17.1M | $-7.36 | — |
| Q4 2023 | $0.00 | NaN% | $-15.8M | $-14.5M | $-6.22 | — |
| FY 2023 | $0.00 | NaN% | $-67.6M | $-62.7M | $-27.04 | — |